Pilot study of carbohydrate sulfotransferase 7 diagnostic utility in non-small cell lung carcinoma

Carbohydrate sulfotransferase 7 in non-small cell lung carcinoma: a clinical pilot diagnostic accuracy study of the biomarker candidate

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN16181999

Enrollment

150

Registered

2016-10-17

Start date

2012-07-04

Completion date

Unknown

Last updated

2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung carcinoma Cancer

Interventions

Patients are recruited consecutively during the routine diagnostic work up for suspected lung carcinoma. CHST7 concentration is determined along with other serum parameters, including routinely used t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age > 18 years 2. Suspected pulmonary malignant disease accompanied with clinical and laboratory signs of inflammation 3. Therapy-naïve

Exclusion criteria

Exclusion criteria: 1. Participant refused to participate 2. Insufficient or unavailable diagnostic information

Design outcomes

Primary

Measure	Time frame
The diagnostic utility of CHST7 in NSCLC, evaluated using area under the curve (AUC) and other statistical measures coming from receiver-operation-characteristic analysis	—

Secondary

Measure	Time frame
Evaluation of multivariate performance conducted using crossvalidation accuracy	—

Countries

Croatia

Contacts

Public ContactZeljko Debeljak

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026